Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Press release

First Tracks Biotherapeutics, Inc. press release

img27758352_0.jpg

img27758352_1.jpg

img27758352_2.jpg

img27758352_3.jpg

img27758352_4.jpg

img27758352_5.jpg

img27758352_6.jpg

img27758352_7.jpg

img27758352_8.jpg

img27758352_9.jpg

img27758352_10.jpg

img27758352_11.jpg

img27758352_12.jpg

img27758352_13.jpg

img27758352_14.jpg

img27758352_15.jpg

img27758352_16.jpg

img27758352_17.jpg

img27758352_18.jpg

img27758352_19.jpg

img27758352_20.jpg

img27758352_21.jpg

img27758352_22.jpg

img27758352_23.jpg

img27758352_24.jpg

img27758352_25.jpg

img27758352_26.jpg

img27758352_27.jpg

img27758352_28.jpg

img27758352_29.jpg

img27758352_30.jpg

img27758352_31.jpg

img27758352_32.jpg

img27758352_33.jpg

img27758352_34.jpg

img27758352_35.jpg

img27758352_36.jpg

img27758352_37.jpg

img27758352_38.jpg

img27758352_39.jpg

img27758352_40.jpg

img27758352_41.jpg

img27758352_42.jpg

img27758352_43.jpg

img27758352_44.jpg

img27758352_45.jpg

img27758352_46.jpg

img27758352_47.jpg

img27758352_48.jpg

img27758352_49.jpg

img27758352_50.jpg

Source: First Tracks Biotherapeutics, Inc.. This release was filed with the U.S. Securities and Exchange Commission on Oct 13, 2026 and is reproduced here as issued. View the filing.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.